Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma

Hiu Yan Chan, Adelina Tsoi, Maria Pik Wong, James C.M. Ho, Elaine Yuen Phin Lee
2016 Nuclear medicine communications  
Objective: Lymphoepithelioma-like carcinoma (LELC) is a rare Epstein-Barr virus (EBV)related disease, which commonly originates from the lung and is associated with more favourable treatment outcomes compared to other non-LELC thoracic carcinomas. Radiological assessment utilizing 18 Fluorine-fluorodeoxyglucose positron emission tomography combined with computed tomography ( 18 F-FDG PET/CT) is important for initial disease staging to tailor the treatment strategy, evaluation of treatment
more » ... se and detection of disease recurrence. The purpose of this article was to highlight the utility of 18 F-FDG PET/CT in different stages of disease evaluation of LELC. Methods: We reviewed 7 patients with histologically proven LELC who underwent 18 F-FDG PET/CT for disease evaluation. Results: We described the 18 F-FDG avidity of LELC (ranged from SUVmax 7.6 to SUVmax 14.5 in our series) and highlighted the clinical values of 18 F-FDG PET/CT in different stages of disease evaluation. 18 F-FDG PET/CT allows accurate evaluation of the primary tumour, its relationship with the surrounding structures and accurate staging. It is also useful in treatment response assessment to monitor the efficacy of the treatment and to decide upon treatment strategy. Given the 18 F-FDG avidity of LELC, 18 F-FDG PET/CT is advantageous in detecting tumour recurrence of LELC. Conclusion: LELC is a rare disease entity associated with EBV and is more prevalent in Asia, where EBV is endemic. LELC is FDG-avid tumour. Although the features on 18 F-FDG PET/CT are not specific, 18 FDG PET/CT offers valuable information on disease management of LELC.
doi:10.1097/mnm.0000000000000475 pmid:26741291 fatcat:sdvq7u7ppbcazeu335sxhopcw4